# Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)

> **NCT07298993** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Weill Medical College of Cornell University** · enrollment: 240 (estimated)

## Conditions studied

- Heart Failure
- HFpEF
- HFpEF - Heart Failure With Preserved Ejection Fraction

## Interventions

- **DRUG:** Placebo (matching)
- **DRUG:** Beta-blockers

## Key facts

- **NCT ID:** NCT07298993
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-02-02
- **Primary completion:** 2029-04
- **Final completion:** 2029-04
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298993, "Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT07298993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*